1. Odds FC. Pathogenic fungi in the 21st century. Trends Microbiol 2000; 8: 200–201.
2. Hartman PG, Sanglard D. Inhibitors of ergosterol biosynthesis as antifungal agents. Curr Pharmaceut Des 1997; 3: 177–208.
3. Warnock DW. Introduction to the management of fungal infection in the compromised host. In: Warnock DW. Richardson MD (eds). Fungal Infection in the Compromised Patient, 2nd ed,/Chichester: John Wiley & Sons, 1990, pp. 23–53.
4. Kibbler CC. Epidemiology of fungal infections. In: Kibbler CC, Mackenzie DWR, Odds FC (eds). Principles and Practice of Clinical Mycology, Chichester: John Wiley & Sons, 1996, pp. 13–21.
5. Ampel NM. Emerging disease issues and fungal pathogens associated with HIV infection. Emerg Infect Dis 1996; 2: 109–116.